Tecon Bio terminates projects, redirects funds to working capital
Tecon Bio (SZSE:002100) has announced the termination of specific fundraising projects, redirecting approximately RMB 50.1 million (approximately $7.03 million USD) to permanently supplement its working capital. The decision, approved by the board and supervisors on March 6, 2025, aims to improve the use of company funds. This change will improve efficiency and support long-term development. Specifically, the "Gansu Tiankang Agricultural Technology Co., Ltd. 30,000 Head Young Pig Breeding and 20,000 Head Fattening Pig Breeding Project” is being terminated. The funds will be transferred to a general bank account for daily operations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Tecon Biology publishes news
Free account required • Unsubscribe anytime